Giant cell arteritis (GCA) is a medium-to-large vessel vasculitis most commonly affecting the aortic arch and carotid branches. Lingual necrosis is a rare complication of GCA caused by lingual artery vasculitis due to ischemia. A delay in diagnosis can result in irreversible complications such as tongue amputation. Our case involves an 83-year-old female patient whose hospital admission for evaluation of stroke-like symptoms was complicated by the development of tongue necrosis, requiring percutaneous endoscopic gastrostomy tube placement for severe odynophagia and dysphagia. The patient was treated with IV glucocorticoids; however, she required tongue amputation due to extensive necrosis as a result of delayed initiation of therapy. Treatment of GCA usually involves an initial high-dose steroid with prolonged steroid taper or immunomodulatory, as relapse is a common occurrence. Prompt diagnosis and appropriate therapy to treat GCA is crucial to prevent the progression of tongue necrosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666295PMC
http://dx.doi.org/10.7759/cureus.74316DOI Listing

Publication Analysis

Top Keywords

lingual necrosis
8
giant cell
8
cell arteritis
8
tongue necrosis
8
necrosis setting
4
setting giant
4
arteritis giant
4
gca
4
arteritis gca
4
gca medium-to-large
4

Similar Publications

Reply to "Comment on Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy".

Oral Oncol

January 2025

Radiation Oncology Unit, REM Radioterapia, 95100 Viagrande, CT, Italy; Department of Medicine and Surgery, University Kore of Enna, 94100 Enna, Italy. Electronic address:

View Article and Find Full Text PDF

: This study aimed to evaluate the role of A-PRF (advanced platelet-rich fibrin) in the enhancement of wound healing and protecting the periodontal health of mandibular second molars after the extraction of mandibular third molars. Additionally, the study assessed the levels of pro-inflammatory cytokines in the gingival crevicular fluid (GCF) of mandibular second molars as markers of inflammation. : Twenty-five systemically healthy adult patients with bilateral removal of impacted mandibular third molars were included.

View Article and Find Full Text PDF

Purpose: To evaluate treatment outcomes and toxicity in patients with stage T1-3N0M0 oral cancer treated with surgery followed by high-dose-rate brachytherapy (HDR-BT).

Methods And Materials: Retrospective study of 50 patients with stage T1-T3N0 tongue and floor-of-mouth cancer who underwent tumour excision (+ elective neck dissection) followed by postoperative HDR-BT due to the presence of negative prognostic factors (close or positive resection margins, lymphovascular and/or perineural invasion, deep invasion). The plastic tube technique (dose: 18 x 3 Gy b.

View Article and Find Full Text PDF

Giant cell arteritis (GCA) is a medium-to-large vessel vasculitis most commonly affecting the aortic arch and carotid branches. Lingual necrosis is a rare complication of GCA caused by lingual artery vasculitis due to ischemia. A delay in diagnosis can result in irreversible complications such as tongue amputation.

View Article and Find Full Text PDF

Protective effects of quercetin against tongue injury and oxidative stress triggered by irinotecan: a histopathological, biochemical and molecular study.

Toxicol Res (Camb)

December 2024

Department of Anatomy and Embryology, Faculty of Medicine, Benha University, Al Nadi Al Ryadi, Qism Benha, Al-Qalyubia Governorate, Benha 13518, Benha, Egypt.

Introduction: About 80% of patients receiving chemotherapeutics suffer from side effects related to the gastrointestinal tract. Irinotecan (CPT-11) is a chemotherapeutic agent usually used in treating solid tumors. Quercetin (QRT), a bioflavonoid, is an antioxidant and scavenger reactive oxygen species scavenger.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!